Parametric Portfolio Associates LLC raised its stake in shares of Orthofix International N.V. (NASDAQ:OFIX) by 21.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,105 shares of the medical device company’s stock after buying an additional 8,604 shares during the period. Parametric Portfolio Associates LLC owned approximately 0.27% of Orthofix International N.V. worth $1,873,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the stock. Norges Bank bought a new stake in Orthofix International N.V. during the fourth quarter valued at about $5,664,000. Bank of New York Mellon Corp increased its stake in Orthofix International N.V. by 122.5% in the first quarter. Bank of New York Mellon Corp now owns 242,068 shares of the medical device company’s stock valued at $9,236,000 after buying an additional 133,281 shares in the last quarter. Ameriprise Financial Inc. increased its stake in Orthofix International N.V. by 23.5% in the first quarter. Ameriprise Financial Inc. now owns 423,655 shares of the medical device company’s stock valued at $16,162,000 after buying an additional 80,710 shares in the last quarter. American Century Companies Inc. increased its stake in Orthofix International N.V. by 68.9% in the first quarter. American Century Companies Inc. now owns 175,522 shares of the medical device company’s stock valued at $6,696,000 after buying an additional 71,599 shares in the last quarter. Finally, Highbridge Capital Management LLC bought a new stake in Orthofix International N.V. during the fourth quarter valued at about $1,023,000. 99.68% of the stock is owned by institutional investors.

Orthofix International N.V. (OFIX) traded up 7.76% during mid-day trading on Tuesday, hitting $48.33. 487,980 shares of the stock were exchanged. The firm’s market capitalization is $872.07 million. Orthofix International N.V. has a 52 week low of $32.51 and a 52 week high of $49.60. The company’s 50-day moving average price is $45.44 and its 200 day moving average price is $40.49.

Orthofix International N.V. (NASDAQ:OFIX) last announced its quarterly earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a negative net margin of 0.82% and a positive return on equity of 10.03%. The firm had revenue of $108.90 million during the quarter, compared to analysts’ expectations of $102.94 million. During the same quarter in the prior year, the company earned $0.41 EPS. The company’s revenue was up 4.6% compared to the same quarter last year. Equities research analysts expect that Orthofix International N.V. will post $1.53 EPS for the current year.

WARNING: This article was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.thecerbatgem.com/2017/08/08/parametric-portfolio-associates-llc-raises-stake-in-orthofix-international-n-v-nasdaqofix-updated-updated-updated.html.

Several equities research analysts have issued reports on the company. BidaskClub downgraded Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Zacks Investment Research raised shares of Orthofix International N.V. from a “sell” rating to a “hold” rating in a report on Thursday, July 6th. BTIG Research initiated coverage on shares of Orthofix International N.V. in a report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price target on the stock. Langenberg & Company reissued a “buy” rating and issued a $53.25 target price on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. Finally, Ladenburg Thalmann Financial Services initiated coverage on Orthofix International N.V. in a research note on Wednesday, June 14th. They issued a “buy” rating and a $53.25 target price on the stock. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Orthofix International N.V. currently has a consensus rating of “Buy” and an average price target of $51.88.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Stock Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related stocks with our FREE daily email newsletter.